11 August 2016
Press ReleasesJames Cowper Kreston are pleased to announce their involvement in the acquisition of Kapitex Healthcare by Tracoe Medical (“the Acquirer” or “the Group”). The Corporate Finance team provided financial due diligence services to the Acquirer.
Based in Germany, Tracoe Medical has been specialising in airway management products, specifically for laryngectomy and tracheostomy patients, since its founding over 55 years ago.
Established in 1991, based in Wetherby, Kapitex is a UK market leader in the development and manufacture of medical devices, serving both hospitals and directly through community channel including wholesalers, pharmacies and dispensing appliance contractors. For more than 20 years Kapitex has been a key distributor of Tracoe products in the UK. Consequently the acquisition presented Tracoe with the opportunity to expand its existing product range as well as consolidate its position in the UK market.
Stephan Kohler, of Tracoe Medical, commented:
“For us Kapitex is the ideal addition to the Group of Companies, opening an array of opportunities not only for Tracoe medical but for Kapitex, too. With the extremely professional assistance of Nick and Tom from James Cowper Kreston this acquisition had the best possible start”.
Nick Rogers, Partner and Head of Corporate Finance at James Cowper Kreston, added:
“We are delighted to have advised Tracoe on this acquisition. Kapitex provides Tracoe with an exciting opportunity to further develop the Group’s capabilities and offering in the UK market. In addition, the worldwide access to resources and support from Tracoe presents Kapitex with an established base to grow its international presence. We wish them every success in the future.”
The James Cowper Kreston team consisted of Partner, Nick Rogers and Corporate Finance Associate Director, Tom Appleby.
For more information on our award winning range of corporate finance services, please call Nick Rogers on +44 (0)118 9590261.
